Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
2.660
+0.050 (1.92%)
Oct 7, 2024, 4:00 PM EDT - Market closed
Poseida Therapeutics Market Cap
Poseida Therapeutics has a market cap or net worth of $258.34 million as of October 7, 2024. Its market cap has increased by 51.61% in one year.
Market Cap
258.34M
Enterprise Value
104.18M
1-Year Change
51.61%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since July 10, 2020, Poseida Therapeutics's market cap has decreased from $948.90M to $258.34M, a decrease of -72.77%. That is a compound annual growth rate of -26.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 4, 2024 | 253.50M | -21.10% |
| Dec 29, 2023 | 321.30M | -29.46% |
| Dec 30, 2022 | 455.50M | 7.00% |
| Dec 31, 2021 | 425.70M | -37.23% |
| Dec 31, 2020 | 678.20M | -28.53% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Procaps Group | 259.50M |
| Instil Bio | 259.25M |
| Sanara MedTech | 258.91M |
| uniQure | 257.25M |
| Design Therapeutics | 255.36M |
| Alpha Teknova | 253.19M |
| Solid Biosciences | 253.18M |
| Zynex | 246.96M |